AN INTRODUCTION to the CHATGILIALOGLU RESEARCH
Reflecting on his fifty years of research, a scientific trajectory that evolved from fundamental Group 14 radical chemistry to the frontiers of chemical biology.
His main contributions began with the development of tris(trimethylsilyl)silane as a radical-based reducing agent (Fluka prize “Reagent of the Year 1990”), which revolutionized synthetic methodology and materials science.
Subsequently, he established the field of biomimetic radical chemistry, providing a molecular understanding of radical processes in cellular environments. Key milestones include the characterization of cis-trans isomerization of the double bonds in membrane lipids, the mono-trans arachidonic acid as a biomarker for free radical stress, the identification of 5',8-cyclopurines as signatures of DNA damage, and the exploration of sulfur-centered radicals in protein modification.
By integrating chemical mechanisms with clinical relevance, this work demonstrates the profound multidisciplinary impact of free radical research in bridging the molecular and medical sciences.
Key technical and scientific advances in lipidomics have been applied to the market for biomedical diagnostics via the spin-off company Lipinutragen founded by Drs Chatgilialoglu and Ferreri in Italy.